REGISTERED NUMBER: 10343457 (England and Wales)

Unaudited Financial Statements for the Year Ended 31st July 2025

for

PMS Pharma Ltd

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

Mr S J Hine

REGISTERED OFFICE:

213 London Road

Hadleigh

Benfleet

Essex

SS7 2RD

REGISTERED NUMBER:

10343457 (England and Wales)

ACCOUNTANTS:

Field & Co LLP

213 London Road

Hadleigh

Benfleet

Essex

SS7 2RD

FIXED ASSETS

Tangible assets

4

4,233

3,700

CURRENT ASSETS

Debtors

5

26,207

22,616

Prepayments and accrued income

49,817

20,000

Cash at bank and in hand

4,776

33,812

80,800

76,428

CREDITORS

Amounts falling due within one year

6

84,907

69,707

NET CURRENT (LIABILITIES)/ASSETS

(4,107

)

6,721

TOTAL ASSETS LESS CURRENT LIABILITIES

126

10,421

CREDITORS

Amounts falling due after more than one year

7

-

(9,640

)

PROVISIONS FOR LIABILITIES

9

(101

)

(776

)

NET ASSETS

25

5

CAPITAL AND RESERVES

Called up share capital

10

5

5

Retained earnings

11

20

-

SHAREHOLDERS' FUNDS

25

5

The Company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st July 2025.

The members have not required the Company to obtain an audit of its financial statements for the year ended 31st July 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the Company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the Company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the Company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 26th April 2026 and were signed by:

Mr S J Hine - Director

1.	STATUTORY INFORMATION

PMS Pharma Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Freehold property

-

not provided

Motor vehicles

-

Straight line over 4 years

Computer equipment

-

20% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Freehold

Motor

Computer

property

vehicles

equipment

Totals

£

£

£

£

COST

At 1st August 2024

3,700

33,100

-

36,800

Additions

-

-

666

666

Disposals

-

(33,100

)

-

(33,100

)

At 31st July 2025

3,700

-

666

4,366

DEPRECIATION

At 1st August 2024

-

33,100

-

33,100

Charge for year

-

-

133

133

Eliminated on disposal

-

(33,100

)

-

(33,100

)

At 31st July 2025

-

-

133

133

NET BOOK VALUE

At 31st July 2025

3,700

-

533

4,233

At 31st July 2024

3,700

-

-

3,700

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Motor

vehicles

£

COST

At 1st August 2024

33,100

Disposals

(33,100

)

At 31st July 2025

-

DEPRECIATION

At 1st August 2024

33,100

Eliminated on disposal

(33,100

)

At 31st July 2025

-

NET BOOK VALUE

At 31st July 2025

-

At 31st July 2024

-

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31/7/25

31/7/24

£

£

Trade debtors

26,207

8,965

Other debtors

-

13,651

26,207

22,616

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31/7/25

31/7/24

£

£

Bank loans and overdrafts (see note 8)

10,335

10,268

Hire purchase contracts

-

17,176

Trade creditors

47,507

18,743

Taxation and social security

27,065

23,520

84,907

69,707

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31/7/25

31/7/24

£

£

Bank loans (see note 8)

-

9,640

8.

LOANS

An analysis of the maturity of loans is given below:

31/7/25

31/7/24

£

£

Amounts falling due within one year or on demand:

Bank overdrafts

695

-

Bank loans

9,640

10,268

10,335

10,268

Amounts falling due between one and two years:

Bank loans - 1-2 years

-

9,640

9.	PROVISIONS FOR LIABILITIES

31/7/25

31/7/24

£

£

Deferred tax

101

776

Deferred

tax

£

Balance at 1st August 2024

776

Credit to Statement of Income and Retained Earnings during year

(675

)

Balance at 31st July 2025

101

10.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31/7/25

31/7/24

value:

£

£

1

Ordinary Share of £1

£1

1

1

1

Ordinary "A" Shares

£1

1

1

1

Ordinary "B" Shares

£1

1

1

1

Ordinary "C" Shares

£1

1

1

1

Ordinary "D" Shares

£1

1

1

5

5

11.

RESERVES

Retained

earnings

£

Profit for the year

52,349

Dividends

(52,329

)

At 31st July 2025

20

12.	ULTIMATE CONTROLLING PARTY

The controlling party is Mr S J Hine.